Snowden Capital Advisors LLC Bristol Myers Squibb CO Transaction History
Snowden Capital Advisors LLC
- $3.12 Billion
- Q4 2024
A detailed history of Snowden Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 69,058 shares of BMY stock, worth $3.72 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
69,058
Previous 104,781
34.09%
Holding current value
$3.72 Million
Previous $5.42 Million
27.98%
% of portfolio
0.13%
Previous 0.16%
Shares
34 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...